You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 3, March 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Immunology
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Dermatology
 •Alert me on articles by topic

Induction of Immunological Antitumor Effects by Adenovirus-Mediated Gene Transfer of B7-1 in a Murine Squamous Cell Carcinoma Cell Line

Yasuhiko Hoshitani, MD; Haruhiko Ishida, MD, PhD; Naoki Otsuki, MD, PhD; Toshiro Shirakawa, MD, PhD; Akinobu Gotoh, MD, PhD; Ken-ichi Nibu, MD, PhD

Arch Otolaryngol Head Neck Surg. 2007;133(3):270-275.

Objective  To evaluate the antitumor immune effects of B7-1 gene expression mediated by adenoviral vectors against squamous cell carcinoma. Transfection of the costimulatory molecule B7-1 gene into certain murine tumors increases antitumor immunity and suppresses tumor growth.

Design  In vitro and in vivo study.

Interventions  A murine squamous cell carcinoma cell line, KLN205, was infected with adenoviral vectors carrying either B7-1 (AdB7) or LacZ (AdCL) genes. Infected cells were injected subcutaneously into the flanks of DBA/2 mice.

Main Outcome Measures  The growth of tumors infected with adenviral vectors was measured.

Results  AdB7-infected cells grew significantly slower than AdCL-infected cells in vivo, while there was no significant difference in the growth rates between the 2 groups in vitro. Moreover, significant growth suppression of rechallenged noninfected parental cells was observed in the mice immunized with AdB7-infected cells but not in those immunized with AdCL-infected cells.

Conclusion  These results suggest that the B7-1 gene has therapeutic potential for immunotherapy against head and neck squamous cell carcinoma.


Author Affiliations: Department of Otolaryngology–Head and Neck Surgery, Graduate School of Medicine (Drs Hoshitani, Ishida, Otsuki, and Nibu), International Center for Medical Research and Treatment, School of Medicine (Dr Shirakawa), Kobe University, Kobe, Japan; and Division of Cell and Gene Therapy, Institute for Advanced Medical Science, Hyogo College of Medicine, Hyogo, Japan (Dr Gotoh).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.